New Products In Brief
This article was originally published in The Gray Sheet
Recent product approvals and launches include Boston Scientific’s Epic iliac artery stent and GE Healthcare’s Q.Freeze PET/CT imaging technology.
You may also be interested in...
Data reports on obesity devices, bone density screening and more.
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.